Brief: IRLAB Appoints Roy Jonebrant As Interim CFO

IRLAB Therapeutics AB

21/08/2025 10:01

Aug 21 (Reuters) - IRLAB Therapeutics AB IRLABa.ST:

APPOINTS ROY JONEBRANT AS INTERIM CFO

ROY JONEBRANT WILL TAKE OVER AS ACTING CFO ON SEPTEMBER 1, 2025

Source text: ID:nMFN523YDN

Further company coverage: [IRLABa.ST]

 (Gdansk Newsroom)

 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))